BioLife Corporate Profile

BioLife Corporate Profile

Financials

2018 Annual Revenue
$11.22 Billion

2018 Gross Profit
$5.97 Billion

2018 Annual Net Income
$1.34 Billion

2018 Fiscal Year
3.05%

 

Credit Rating

guaranteed by Baxalta, Inc., which senior unsecured notes are Investment Grade BBB+ by S&P

BioLife Corporate Profile

BioLife Corporate Profile

Baxalta is a bio-pharmaceutical company which was founded in 2015. That same year, Baxalta was acquired by Shire PLC (SHPGF), a biotechnology company focused on serving people with rare diseases and other specialized conditions worldwide. The company markets its products through wholesalers, distributors, and pharmacies.

ExchangeRight

1055 E. Colorado Blvd, Suite 310
Pasadena, CA 91106

Phone: (855) 317-4448
Fax: (877) 711-4047
Email: info@exchangeright.com

Subscribe

Receive our investment announcements and equity updates.